IMC Chicago’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.16M Buy
137,900
+61,600
+81% +$5.21M ﹤0.01% 1603
2026
Q1
$7.58M Buy
76,300
+25,800
+51% +$3.37M ﹤0.01% 1480
2025
Q4
$6.14M Sell
50,500
-20,400
-29% -$2.56M ﹤0.01% 1584
2025
Q3
$7.95M Sell
70,900
-8,800
-11% -$1.03M ﹤0.01% 1277
2025
Q2
$10.7M Buy
79,700
+19,100
+32% +$2.1M ﹤0.01% 988
2025
Q1
$4.08M Sell
60,600
-19,800
-25% -$1.36M ﹤0.01% 1342
2024
Q4
$5.01M Buy
80,400
+61,000
+314% +$5.68M ﹤0.01% 1224
2024
Q3
$3.05M Buy
+19,400
New +$2.99M ﹤0.01% 1403

Other funds holding TMDX

IMC Chicago's TMDX Position: Q2 2026 in Review

IMC Chicago increased its Transmedics (TMDX) stake by 227% in Q2 2026, buying an estimated $5.32M and bringing the position to 90,515 shares worth $6.01M. The position accounts for ﹤0.01% of the portfolio, ranked #1944.

IMC Chicago first reported a position in TMDX in Q4 2024 and has held it in 3 quarters since. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • IMC Chicago held 90,515 shares of Transmedics worth $6.01M as of Q2 2026.
  • IMC Chicago bought 62,823 Transmedics shares in Q2 2026, an estimated $5.32M.
  • Transmedics made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #1944 holding.
  • IMC Chicago first reported a position in Transmedics in Q4 2024 and has held it in 3 quarters since.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.